- Home
- NGEN vs HRTX Comparison
NGEN vs HRTX Comparison
Compare NGEN & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | HRTX |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Canada | United States |
| Employees | 9 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 228.3M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NGEN | HRTX |
|---|---|---|
| Price | $2.24 | $0.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $4.50 |
| AVG Volume (30 Days) | 1.5M | ★ 4.2M |
| Earning Date | 04-02-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $1.70 | $0.38 |
| 52 Week High | $5.93 | $2.30 |
Technical Indicators
Market Signals| Indicator | NGEN | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 26.87 |
| Support Level | $1.70 | N/A |
| Resistance Level | $4.44 | $1.34 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 88.52 | 5.75 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.